Share Price and Basic Stock Data
Last Updated: October 10, 2025, 9:10 pm
| PEG Ratio | 0.16 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Gillanders Arbuthnot & Company Ltd, operating in the Plantations – Tea & Coffee industry, has a market capitalization of ₹250 Cr. The company reported a price of ₹116 per share with 27 in Net Profit. The latest data shows Promoters holding 69.05%, while FIIs and DIIs hold 0.00% and 0.31%, respectively. The public holds 30.60% of the shares, indicating a diverse shareholder base of 10,447 investors. Looking at the financials, the company has shown a concerning Operating Profit Margin (OPM) of -0.14%. The Cash Conversion Cycle (CCC) stands at 146 days, reflecting the efficiency of the company in managing its working capital.
Profitability and Efficiency Metrics
Analyzing the profitability metrics, the company has a Price-to-Earnings (P/E) ratio of 12.0, Return on Equity (ROE) of 6.83%, and Return on Capital Employed (ROCE) of 6.80%. The Interest Coverage Ratio (ICR) at -1.40x raises concerns about the company’s ability to meet interest obligations. The Net Profit margin of 27 indicates a modest bottom-line performance. Comparing these figures to sector averages can provide insights into the company’s relative efficiency and profitability within the industry.
Balance Sheet Strength and Financial Ratios
With reserves amounting to ₹224 Cr and borrowings of ₹139 Cr, Gillanders Arbuthnot & Company Ltd maintains a healthy reserve base relative to its debt levels. The Price-to-Book Value (P/BV) ratio of 0.71x suggests that the stock may be undervalued in the market. However, the negative ICR indicates a potential strain on the company’s financial health due to high debt obligations. Monitoring liquidity ratios and working capital efficiency will be crucial for sustaining financial stability.
Shareholding Pattern and Investor Confidence
Examining the shareholding pattern, the consistent high promoter holding indicates confidence in the company’s performance. The negligible FII and DII holdings suggest limited institutional interest, which can impact the stock’s liquidity and price movements. Changes in the shareholding pattern over time can influence market perception and valuation, reflecting investor sentiment towards the company’s future prospects and growth trajectory.
Outlook, Risks, and Final Insight
Looking ahead, Gillanders Arbuthnot & Company Ltd faces potential growth drivers in expanding its market presence and enhancing operational efficiency. However, risks such as high debt levels and negative ICR pose challenges to sustainable profitability. Strengthening financial ratios, improving interest coverage, and diversifying shareholder base could enhance the company’s performance. Considering the current financial indicators, cautious optimism is advised, with a focus on mitigating risks to drive long-term value creation for investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Gillanders Arbuthnot & Company Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 414 Cr. | 192 | 357/162 | 74.2 | 125 | 0.00 % | 3.22 % | 2.86 % | 10.0 |
| Diana Tea Company Ltd | 46.0 Cr. | 30.6 | 49.8/26.0 | 43.0 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 122 Cr. | 135 | 196/126 | 102 | 213 | 1.11 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 3.90 Cr. | 6.17 | 8.56/5.60 | 9.43 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 129 Cr. | 415 | 689/0.00 | 13.8 | 455 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 9,127.00 Cr | 401.48 | 111.04 | 243.71 | 0.40% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 124.81 | 143.56 | 103.24 | 77.42 | 87.68 | 105.42 | 101.43 | 68.75 | 84.85 | 126.75 | 127.64 | 103.94 | 88.37 |
| Expenses | 121.76 | 119.46 | 101.82 | 94.04 | 90.30 | 96.42 | 125.76 | 84.41 | 90.11 | 101.46 | 119.87 | 106.03 | 88.49 |
| Operating Profit | 3.05 | 24.10 | 1.42 | -16.62 | -2.62 | 9.00 | -24.33 | -15.66 | -5.26 | 25.29 | 7.77 | -2.09 | -0.12 |
| OPM % | 2.44% | 16.79% | 1.38% | -21.47% | -2.99% | 8.54% | -23.99% | -22.78% | -6.20% | 19.95% | 6.09% | -2.01% | -0.14% |
| Other Income | 12.60 | 3.91 | 6.07 | 7.67 | 4.59 | 1.86 | 8.25 | -1.07 | 1.74 | 3.53 | 13.23 | 3.99 | 0.49 |
| Interest | 5.24 | 4.39 | 3.99 | 4.42 | 3.98 | 3.51 | 3.94 | 2.86 | 3.46 | 2.85 | 2.95 | 3.10 | 3.24 |
| Depreciation | 2.95 | 3.09 | 3.01 | 2.91 | 3.03 | 3.15 | 2.86 | 2.72 | 2.67 | 2.78 | 2.80 | 2.61 | 2.65 |
| Profit before tax | 7.46 | 20.53 | 0.49 | -16.28 | -5.04 | 4.20 | -22.88 | -22.31 | -9.65 | 23.19 | 15.25 | -3.81 | -5.52 |
| Tax % | 8.58% | 11.89% | -51.02% | -33.54% | 4.37% | 13.33% | -2.32% | 10.49% | 1.76% | 7.37% | 14.56% | -153.54% | -1.27% |
| Net Profit | 6.81 | 18.09 | 0.74 | -10.81 | -5.26 | 3.64 | -22.35 | -24.65 | -9.82 | 21.47 | 13.03 | 2.04 | -5.46 |
| EPS in Rs | 3.19 | 8.48 | 0.35 | -5.07 | -2.46 | 1.71 | -10.47 | -11.55 | -4.60 | 10.06 | 6.11 | 0.96 | -2.56 |
Last Updated: August 20, 2025, 10:30 am
Below is a detailed analysis of the quarterly data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 88.37 Cr.. The value appears to be declining and may need further review. It has decreased from 103.94 Cr. (Mar 2025) to 88.37 Cr., marking a decrease of 15.57 Cr..
- For Expenses, as of Jun 2025, the value is 88.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 106.03 Cr. (Mar 2025) to 88.49 Cr., marking a decrease of 17.54 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.12 Cr.. The value appears strong and on an upward trend. It has increased from -2.09 Cr. (Mar 2025) to -0.12 Cr., marking an increase of 1.97 Cr..
- For OPM %, as of Jun 2025, the value is -0.14%. The value appears strong and on an upward trend. It has increased from -2.01% (Mar 2025) to -0.14%, marking an increase of 1.87%.
- For Other Income, as of Jun 2025, the value is 0.49 Cr.. The value appears to be declining and may need further review. It has decreased from 3.99 Cr. (Mar 2025) to 0.49 Cr., marking a decrease of 3.50 Cr..
- For Interest, as of Jun 2025, the value is 3.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.10 Cr. (Mar 2025) to 3.24 Cr., marking an increase of 0.14 Cr..
- For Depreciation, as of Jun 2025, the value is 2.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.61 Cr. (Mar 2025) to 2.65 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is -5.52 Cr.. The value appears to be declining and may need further review. It has decreased from -3.81 Cr. (Mar 2025) to -5.52 Cr., marking a decrease of 1.71 Cr..
- For Tax %, as of Jun 2025, the value is -1.27%. The value appears to be increasing, which may not be favorable. It has increased from -153.54% (Mar 2025) to -1.27%, marking an increase of 152.27%.
- For Net Profit, as of Jun 2025, the value is -5.46 Cr.. The value appears to be declining and may need further review. It has decreased from 2.04 Cr. (Mar 2025) to -5.46 Cr., marking a decrease of 7.50 Cr..
- For EPS in Rs, as of Jun 2025, the value is -2.56. The value appears to be declining and may need further review. It has decreased from 0.96 (Mar 2025) to -2.56, marking a decrease of 3.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:48 pm
| Metric | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 355 | 863 | 817 | 681 | 665 | 751 | 660 | 431 | 406 | 449 | 363 | 443 |
| Expenses | 333 | 821 | 812 | 653 | 615 | 686 | 632 | 400 | 377 | 437 | 397 | 417 |
| Operating Profit | 22 | 42 | 5 | 28 | 50 | 65 | 28 | 31 | 30 | 12 | -34 | 26 |
| OPM % | 6% | 5% | 1% | 4% | 7% | 9% | 4% | 7% | 7% | 3% | -9% | 6% |
| Other Income | 11 | 9 | 12 | 30 | 21 | 12 | 26 | 7 | 17 | 30 | 14 | 22 |
| Interest | 10 | 42 | 51 | 54 | 50 | 50 | 48 | 37 | 23 | 18 | 14 | 12 |
| Depreciation | 9 | 21 | 19 | 22 | 24 | 20 | 20 | 16 | 12 | 12 | 12 | 11 |
| Profit before tax | 14 | -12 | -53 | -18 | -4 | 7 | -12 | -15 | 11 | 12 | -46 | 25 |
| Tax % | 21% | -27% | 4% | 4% | 112% | 95% | 22% | 2% | -42% | -22% | 6% | -7% |
| Net Profit | 11 | -9 | -55 | -19 | -9 | 0 | -15 | -16 | 16 | 15 | -49 | 27 |
| EPS in Rs | 6.69 | -4.16 | -25.93 | -8.83 | -4.02 | 0.15 | -7.13 | -7.32 | 7.66 | 6.94 | -22.78 | 12.52 |
| Dividend Payout % | 25% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -511.11% | 65.45% | 52.63% | 100.00% | -6.67% | 200.00% | -6.25% | -426.67% | 155.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | 576.57% | -12.82% | 47.37% | -106.67% | 206.67% | -206.25% | -420.42% | 581.77% |
Gillanders Arbuthnot & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -8% |
| 3 Years: | 3% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 21% |
| 3 Years: | 0% |
| TTM: | 139% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 34% |
| 3 Years: | 21% |
| 1 Year: | 42% |
| Return on Equity | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -2% |
| 3 Years: | -4% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 4:45 am
Balance Sheet
Last Updated: May 13, 2025, 3:30 pm
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 107 | 266 | 155 | 262 | 271 | 268 | 255 | 231 | 248 | 255 | 196 | 224 |
| Borrowings | 91 | 456 | 480 | 449 | 424 | 392 | 366 | 227 | 183 | 145 | 129 | 139 |
| Other Liabilities | 72 | 242 | 209 | 203 | 225 | 244 | 214 | 145 | 144 | 129 | 130 | 130 |
| Total Liabilities | 281 | 985 | 865 | 936 | 942 | 925 | 857 | 624 | 597 | 550 | 477 | 514 |
| Fixed Assets | 112 | 421 | 310 | 441 | 432 | 427 | 421 | 315 | 312 | 298 | 263 | 256 |
| CWIP | 10 | 11 | 4 | 9 | 17 | 14 | 15 | 14 | 12 | 11 | 9 | 13 |
| Investments | 13 | 28 | 28 | 29 | 34 | 29 | 17 | 8 | 3 | 0 | 0 | 0 |
| Other Assets | 145 | 525 | 522 | 457 | 460 | 454 | 404 | 287 | 271 | 241 | 205 | 245 |
| Total Assets | 281 | 985 | 865 | 936 | 942 | 925 | 857 | 624 | 597 | 550 | 477 | 514 |
Below is a detailed analysis of the balance sheet data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 21.00 Cr..
- For Reserves, as of Mar 2025, the value is 224.00 Cr.. The value appears strong and on an upward trend. It has increased from 196.00 Cr. (Mar 2024) to 224.00 Cr., marking an increase of 28.00 Cr..
- For Borrowings, as of Mar 2025, the value is 139.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 129.00 Cr. (Mar 2024) to 139.00 Cr., marking an increase of 10.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 130.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 130.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 514.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 477.00 Cr. (Mar 2024) to 514.00 Cr., marking an increase of 37.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 256.00 Cr.. The value appears to be declining and may need further review. It has decreased from 263.00 Cr. (Mar 2024) to 256.00 Cr., marking a decrease of 7.00 Cr..
- For CWIP, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 4.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 245.00 Cr.. The value appears strong and on an upward trend. It has increased from 205.00 Cr. (Mar 2024) to 245.00 Cr., marking an increase of 40.00 Cr..
- For Total Assets, as of Mar 2025, the value is 514.00 Cr.. The value appears strong and on an upward trend. It has increased from 477.00 Cr. (Mar 2024) to 514.00 Cr., marking an increase of 37.00 Cr..
Notably, the Reserves (224.00 Cr.) exceed the Borrowings (139.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -69.00 | -414.00 | -475.00 | -421.00 | -374.00 | -327.00 | -338.00 | -196.00 | -153.00 | -133.00 | -163.00 | -113.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 56 | 57 | 54 | 53 | 47 | 45 | 54 | 36 | 21 | 29 | 51 |
| Inventory Days | 130 | 135 | 156 | 207 | 253 | 219 | 206 | 240 | 389 | 287 | 314 | 225 |
| Days Payable | 97 | 92 | 112 | 148 | 180 | 166 | 164 | 163 | 220 | 129 | 164 | 130 |
| Cash Conversion Cycle | 59 | 99 | 101 | 113 | 126 | 100 | 87 | 130 | 204 | 179 | 180 | 146 |
| Working Capital Days | 72 | -21 | 1 | -6 | -24 | -25 | -47 | -11 | 2 | -1 | -11 | -7 |
| ROCE % | 10% | -0% | 1% | 6% | 8% | 4% | 4% | 7% | 4% | -8% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -22.78 | 6.95 | 7.66 | -7.32 | -7.13 |
| Diluted EPS (Rs.) | -22.78 | 6.95 | 7.66 | -7.32 | -7.13 |
| Cash EPS (Rs.) | -17.27 | 12.55 | 13.49 | 0.19 | 2.08 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 101.89 | 129.69 | 126.44 | 118.37 | 129.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 101.89 | 129.69 | 126.44 | 118.37 | 129.29 |
| Revenue From Operations / Share (Rs.) | 170.22 | 210.39 | 190.42 | 201.83 | 309.26 |
| PBDIT / Share (Rs.) | -9.36 | 14.78 | 22.12 | 18.70 | 21.23 |
| PBIT / Share (Rs.) | -14.87 | 9.18 | 16.29 | 11.19 | 12.02 |
| PBT / Share (Rs.) | -21.56 | 5.71 | 5.38 | -7.15 | -5.85 |
| Net Profit / Share (Rs.) | -22.78 | 6.95 | 7.66 | -7.32 | -7.13 |
| NP After MI And SOA / Share (Rs.) | -22.78 | 6.95 | 7.66 | -7.32 | -7.13 |
| PBDIT Margin (%) | -5.50 | 7.02 | 11.61 | 9.26 | 6.86 |
| PBIT Margin (%) | -8.73 | 4.36 | 8.55 | 5.54 | 3.88 |
| PBT Margin (%) | -12.66 | 2.71 | 2.82 | -3.54 | -1.89 |
| Net Profit Margin (%) | -13.38 | 3.30 | 4.02 | -3.62 | -2.30 |
| NP After MI And SOA Margin (%) | -13.38 | 3.30 | 4.02 | -3.62 | -2.30 |
| Return on Networth / Equity (%) | -22.35 | 5.35 | 6.05 | -6.18 | -5.51 |
| Return on Capital Employeed (%) | -12.43 | 6.06 | 9.99 | 6.96 | 6.28 |
| Return On Assets (%) | -10.19 | 2.69 | 2.73 | -2.50 | -1.77 |
| Long Term Debt / Equity (X) | 0.08 | 0.09 | 0.21 | 0.30 | 0.40 |
| Total Debt / Equity (X) | 0.53 | 0.47 | 0.63 | 0.73 | 1.06 |
| Asset Turnover Ratio (%) | 0.70 | 0.78 | 0.64 | 0.56 | 0.74 |
| Current Ratio (X) | 0.85 | 1.01 | 1.03 | 0.99 | 0.87 |
| Quick Ratio (X) | 0.36 | 0.47 | 0.50 | 0.61 | 0.50 |
| Inventory Turnover Ratio (X) | 0.52 | 0.78 | 0.95 | 0.57 | 1.13 |
| Interest Coverage Ratio (X) | -1.40 | 1.75 | 2.03 | 1.08 | 0.94 |
| Interest Coverage Ratio (Post Tax) (X) | -2.41 | 1.23 | 1.70 | 0.63 | 0.48 |
| Enterprise Value (Cr.) | 282.86 | 273.58 | 318.10 | 271.78 | 307.23 |
| EV / Net Operating Revenue (X) | 0.77 | 0.60 | 0.78 | 0.63 | 0.46 |
| EV / EBITDA (X) | -14.15 | 8.67 | 6.74 | 6.81 | 6.78 |
| MarketCap / Net Operating Revenue (X) | 0.43 | 0.29 | 0.34 | 0.21 | 0.06 |
| Price / BV (X) | 0.71 | 0.47 | 0.51 | 0.36 | 0.14 |
| Price / Net Operating Revenue (X) | 0.43 | 0.29 | 0.34 | 0.21 | 0.06 |
| EarningsYield | -0.31 | 0.11 | 0.11 | -0.16 | -0.37 |
After reviewing the key financial ratios for Gillanders Arbuthnot & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 5. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
- For Diluted EPS (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 5. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
- For Cash EPS (Rs.), as of Mar 24, the value is -17.27. This value is below the healthy minimum of 3. It has decreased from 12.55 (Mar 23) to -17.27, marking a decrease of 29.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.89. It has decreased from 129.69 (Mar 23) to 101.89, marking a decrease of 27.80.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.89. It has decreased from 129.69 (Mar 23) to 101.89, marking a decrease of 27.80.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 170.22. It has decreased from 210.39 (Mar 23) to 170.22, marking a decrease of 40.17.
- For PBDIT / Share (Rs.), as of Mar 24, the value is -9.36. This value is below the healthy minimum of 2. It has decreased from 14.78 (Mar 23) to -9.36, marking a decrease of 24.14.
- For PBIT / Share (Rs.), as of Mar 24, the value is -14.87. This value is below the healthy minimum of 0. It has decreased from 9.18 (Mar 23) to -14.87, marking a decrease of 24.05.
- For PBT / Share (Rs.), as of Mar 24, the value is -21.56. This value is below the healthy minimum of 0. It has decreased from 5.71 (Mar 23) to -21.56, marking a decrease of 27.27.
- For Net Profit / Share (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 2. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 2. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
- For PBDIT Margin (%), as of Mar 24, the value is -5.50. This value is below the healthy minimum of 10. It has decreased from 7.02 (Mar 23) to -5.50, marking a decrease of 12.52.
- For PBIT Margin (%), as of Mar 24, the value is -8.73. This value is below the healthy minimum of 10. It has decreased from 4.36 (Mar 23) to -8.73, marking a decrease of 13.09.
- For PBT Margin (%), as of Mar 24, the value is -12.66. This value is below the healthy minimum of 10. It has decreased from 2.71 (Mar 23) to -12.66, marking a decrease of 15.37.
- For Net Profit Margin (%), as of Mar 24, the value is -13.38. This value is below the healthy minimum of 5. It has decreased from 3.30 (Mar 23) to -13.38, marking a decrease of 16.68.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is -13.38. This value is below the healthy minimum of 8. It has decreased from 3.30 (Mar 23) to -13.38, marking a decrease of 16.68.
- For Return on Networth / Equity (%), as of Mar 24, the value is -22.35. This value is below the healthy minimum of 15. It has decreased from 5.35 (Mar 23) to -22.35, marking a decrease of 27.70.
- For Return on Capital Employeed (%), as of Mar 24, the value is -12.43. This value is below the healthy minimum of 10. It has decreased from 6.06 (Mar 23) to -12.43, marking a decrease of 18.49.
- For Return On Assets (%), as of Mar 24, the value is -10.19. This value is below the healthy minimum of 5. It has decreased from 2.69 (Mar 23) to -10.19, marking a decrease of 12.88.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.08, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.53. This value is within the healthy range. It has increased from 0.47 (Mar 23) to 0.53, marking an increase of 0.06.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.70. It has decreased from 0.78 (Mar 23) to 0.70, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 24, the value is 0.85. This value is below the healthy minimum of 1.5. It has decreased from 1.01 (Mar 23) to 0.85, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 24, the value is 0.36. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 23) to 0.36, marking a decrease of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.52. This value is below the healthy minimum of 4. It has decreased from 0.78 (Mar 23) to 0.52, marking a decrease of 0.26.
- For Interest Coverage Ratio (X), as of Mar 24, the value is -1.40. This value is below the healthy minimum of 3. It has decreased from 1.75 (Mar 23) to -1.40, marking a decrease of 3.15.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -2.41. This value is below the healthy minimum of 3. It has decreased from 1.23 (Mar 23) to -2.41, marking a decrease of 3.64.
- For Enterprise Value (Cr.), as of Mar 24, the value is 282.86. It has increased from 273.58 (Mar 23) to 282.86, marking an increase of 9.28.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.60 (Mar 23) to 0.77, marking an increase of 0.17.
- For EV / EBITDA (X), as of Mar 24, the value is -14.15. This value is below the healthy minimum of 5. It has decreased from 8.67 (Mar 23) to -14.15, marking a decrease of 22.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.43. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 23) to 0.43, marking an increase of 0.14.
- For Price / BV (X), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 23) to 0.71, marking an increase of 0.24.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.43. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 23) to 0.43, marking an increase of 0.14.
- For EarningsYield, as of Mar 24, the value is -0.31. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 23) to -0.31, marking a decrease of 0.42.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillanders Arbuthnot & Company Ltd:
- Net Profit Margin: -13.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -12.43% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -22.35% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -2.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.36
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.1 (Industry average Stock P/E: 88.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.53
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -13.38%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | C-4, Gillander House, Netaji Subhas Road Kolkata West Bengal 700001 | secretarial@gillandersarbuthnot.com http://www.gillandersarbuthnot.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arun Kumar Kothari | Chairman |
| Mr. Mahesh Sodhani | Managing Director & CEO |
| Mrs. Prabhawati Devi Kothari | Non Executive Director |
| Mr. Arvind Baheti | Independent Director |
| Mr. Charudatta Raghvendra Prayag | Independent Director |
| Mr. Kothaneth Ashok | Independent Director |
FAQ
What is the intrinsic value of Gillanders Arbuthnot & Company Ltd?
Gillanders Arbuthnot & Company Ltd's intrinsic value (as of 10 October 2025) is 83.96 which is 33.89% lower the current market price of 127.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹274 Cr. market cap, FY2025-2026 high/low of 152/80.2, reserves of ₹224 Cr, and liabilities of 514 Cr.
What is the Market Cap of Gillanders Arbuthnot & Company Ltd?
The Market Cap of Gillanders Arbuthnot & Company Ltd is 274 Cr..
What is the current Stock Price of Gillanders Arbuthnot & Company Ltd as on 10 October 2025?
The current stock price of Gillanders Arbuthnot & Company Ltd as on 10 October 2025 is 127.
What is the High / Low of Gillanders Arbuthnot & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gillanders Arbuthnot & Company Ltd stocks is 152/80.2.
What is the Stock P/E of Gillanders Arbuthnot & Company Ltd?
The Stock P/E of Gillanders Arbuthnot & Company Ltd is 13.1.
What is the Book Value of Gillanders Arbuthnot & Company Ltd?
The Book Value of Gillanders Arbuthnot & Company Ltd is 115.
What is the Dividend Yield of Gillanders Arbuthnot & Company Ltd?
The Dividend Yield of Gillanders Arbuthnot & Company Ltd is 0.00 %.
What is the ROCE of Gillanders Arbuthnot & Company Ltd?
The ROCE of Gillanders Arbuthnot & Company Ltd is 6.80 %.
What is the ROE of Gillanders Arbuthnot & Company Ltd?
The ROE of Gillanders Arbuthnot & Company Ltd is 6.83 %.
What is the Face Value of Gillanders Arbuthnot & Company Ltd?
The Face Value of Gillanders Arbuthnot & Company Ltd is 10.0.